{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, IDs, or identifiers along with bioactivity metrics, numeric values, and units."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Hamblett et al. Clin Cancer Res 2004, 10: 7063-7070 investigated in detail the drug loading of monomethyl auristatin E (MMAE) onto an anti-CD30 monoclonal antibody, and found that the IC50 potency measurement of the conjugate increased with the number of drug molecules coupled. \n\nNote: Unfortunately, there is only one sentence that contains a specific molecule name (MMAE), a bioactivity metric (IC50), but it does not contain a specific numeric value for that metric and a unit for that value. Therefore, the output is limited. If more text is provided, I may be able to extract more relevant sentences."}
{"final_json": [{"molecule_name": "MMAE", "protein_target_name": "CD30", "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The compound of the invention should possess an IC50 of &lt;100nM, preferably &lt;1 nM, more preferably &lt;10pM, and even more preferably &lt;0.1 pM.\n* It is preferable if the compound has an IC50 of up to 10-fold lower (i.e. 10-fold more potent) than the therapeutic agent when unconjugated.\n* The IC50 may be at least 10-fold lower (which is the same as 10% of the original IC50) and preferably the potency will go up to 100% of the unconjugated IC50.\n* The compound should possess a murine serum half-life of at least 2 hours, preferably 4 hours, alternatively 8, 16, 32, 64 or 128 hours.\n* The compound preferably has a serum half- life of up to 5 times higher than the carrier molecule when unconjugated, preferably up to 10 times higher.\n* An increase of half-life up to 10-fold increase is desirable (e.g. 4 hrs to 20hrs in mice)."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<100nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<1 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<10pM", "unit": "pM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<0.1 pM", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The unmodified antibody with a Kd of 25nM showed a slightly reduced affinity for HER2 at 42nM upon reduction but this was regained when the antibody was first conjugated with SPDP to introduce more thiols and then reduced, Kd=24.9nM. \n\nNote that there is only one sentence that meets the criteria, as the rest of the text does not provide specific molecule names, bioactivity metrics, numeric values, and units."}
{"final_json": [{"molecule_name": "unmodified antibody", "protein_target_name": "HER2", "binding_metric": "Kd", "value": "25", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "unmodified antibody", "protein_target_name": "HER2", "binding_metric": "Kd", "value": "42", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "antibody conjugated with SPDP", "protein_target_name": "HER2", "binding_metric": "Kd", "value": "24.9", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe plot (Figure 21) shows that the ADC with 3.9 drugs (average DAR) loaded, substantially retained its binding affinity (\u039a<sub>\u03ac</sub> declines slightly from 2.5nM to 3.3nM, \nThe plot (Figure 21) shows that the ADC with 8.2 drugs loaded, substantially retained its binding affinity (Kd declines slightly from 2.5nM to 15.5nM). \nIf the conjugation reaction is pushed further, conjugating to all but one of the surface lysine residues (1 1/12), the scFv binding is reduced but not lost (K<sub>d</sub>=27.5nM)."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "2.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "3.3", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "2.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Kd", "value": "15.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv", "protein_target_name": null, "binding_metric": "Kd", "value": "27.5", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "The plot (Figure 30) shows that, the ADC (scFv TCT-P5C5(1)) with 8 drugs loaded, substantially retained its binding affinity (Kd declines slightly from 7nM to 13nM)."}
{"final_json": [{"molecule_name": "scFv TCT-P5C5(1)", "protein_target_name": null, "binding_metric": "Kd", "value": "7nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv TCT-P5C5(1)", "protein_target_name": null, "binding_metric": "Kd", "value": "13nM", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe scFv (TCT)-Acetate DAR 15 had an association rate of 5.93x10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 1.71x10<sup>-2</sup> s<sup>-1</sup>, giving an overall binding Kd of 2.9nM.\nThe scFv (TCT) which had an association rate of 2.8x10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 4.17x1 <sup>-\"3</sup> s-\\ with an overall binding Kd of 1.49nM, indicating no loss of binding function.\nThe scFv (TCT1067)-Acetate DAR 16 had an association rate of 3.63x10<sup>e</sup> IVrV and a dissociation rate of 7.64x10<sup>-5</sup> s<sup>-1</sup>, giving an overall binding Kd of 21 pM.\nThe scFv (TCT1067) which had an association rate of 3.9x10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 3.7x10<sup>-5</sup> s<sup>-1</sup>, with an overall binding Kd of 9.5 pM, indicating no loss of binding."}
{"final_json": [{"molecule_name": "scFv (TCT)-Acetate DAR 15", "protein_target_name": null, "binding_metric": "Kd", "value": "2.9", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT)", "protein_target_name": null, "binding_metric": "Kd", "value": "1.49", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)-Acetate DAR 16", "protein_target_name": null, "binding_metric": "Kd", "value": "21", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)", "protein_target_name": null, "binding_metric": "Kd", "value": "9.5", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe scFv (TCT)-MMAF-C5 1 DAR 5.6 had an association rate of 7.7x10<sup>5</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 4.2x10 <sup>-3</sup> s<sup>-1</sup> giving an overall binding Kd of 5.4nM.\nThe scFv (TCT)-MMAF-C5 DAR 6.8 had an association rate of 1.2x10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 4.2x10<sup>\"3</sup> S<sup>-1</sup> giving an overall binding Kd of 3.6nM.\nThis was essentially unchanged compared to the unmodified scFv (TCT) which had an association rate of 2.8x10<sup>6</sup> M<sup>-1</sup>s<sup>_1</sup> and a dissociation rate of 4.17x10<sup>-3</sup> s<sup>-1</sup>, with an overall binding Kd of 1.49 nM, indicating no loss of binding function."}
{"final_json": [{"molecule_name": "scFv (TCT)-MMAF-C5 1 DAR 5.6", "protein_target_name": null, "binding_metric": "Kd", "value": "5.4", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT)-MMAF-C5 DAR 6.8", "protein_target_name": null, "binding_metric": "Kd", "value": "3.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT)", "protein_target_name": null, "binding_metric": "Kd", "value": "1.49", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "The scFv (TCT1067)-MMAF-C5 DAR 5.2 had an association rate of 1.8x10^6 M^-1s^-1 and a dissociation rate of 3.4x10^5 s^-1 giving an overall binding Kd of 19.6pM.\nThe scFv (TCT)-MMAF-C5 DAR 7.1 had an association rate of 4.6x10^6 M^-1s^-1 and a dissociation rate of 1.7x10^5 s^-1, giving an overall binding Kd of 3.8 pM.\nThis was essentially unchanged compared to the unmodified scFv (TCT1067) which had an association rate of 3.9x10^6 M^-1s^-1 and a dissociation rate of 3.7x10^5 s^-1, with an overall binding Kd of 9.5 pM."}
{"final_json": [{"molecule_name": "scFv (TCT1067)-MMAF-C5 DAR 5.2", "protein_target_name": null, "binding_metric": "Kd", "value": "19.6", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT)-MMAF-C5 DAR 7.1", "protein_target_name": null, "binding_metric": "Kd", "value": "3.8", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)", "protein_target_name": null, "binding_metric": "Kd", "value": "9.5", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe scFv (TCT1067)-P5-C5 DAR 10.9 had an association rate of 2.36x10<sup>5</sup> M V<sup>1</sup> and a dissociation rate of 7.13.x10 <sup>5</sup> s<sup>\"1</sup>, giving an overall binding Kd of 302 pM.\nThere was a moderate reduction in the association rate (due to reversible steric hindrance of the antibody binding site by the high number of attached payloads), but once bound, there was insignificant effect on the dissociation rate compared to the unmodified scFv (TCT1067) which had an association rate of 3.9x10<sup>6</sup> M<sup>\"1</sup>s<sup>\"1</sup> and a dissociation rate of 3.7x10 <sup>5</sup> s <sup>1</sup>, with an overall binding Kd of 9.5 pM."}
{"final_json": [{"molecule_name": "scFv (TCT1067)-P5-C5 DAR 10.9", "protein_target_name": null, "binding_metric": "Kd", "value": "302", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)", "protein_target_name": null, "binding_metric": "Kd", "value": "9.5", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "The scFv (TCT1067)-Auristatin-F-C5 DAR 3.3 had an association rate of 5.56 x 10^5 M^\"1s^\"1 and a dissociation rate of 1.82 x10^\"5 s^\"1, giving an overall binding Kd of 32.8pM.\nThe scFv (TCT1067)-Auristatin-F-C5 DAR 5.65 had an association rate of 3.36x10^5 M^\"V^1 and a dissociation rate of 1.35 x10^\"5 s^~1, giving an overall binding Kd of 40.3 pM.\nThe scFv (TCT1067)-Auristatin-F-C5 DAR 1 1.9 had an association rate of 2.17x10^4 M^\"1s^\"1 and a dissociation rate of 1.76x10^\"5 s^~ giving an overall binding Kd of 810 pM.\nThe low and medium DAR samples had affinities that were very similar to the unmodified scFv (TCT1067) which had an association rate of 3.9x10^6 M^\"1s^\"1 and a dissociation rate of 3.7x10^\"5 s^\"1, with an overall binding Kd of 9.5 pM."}
{"final_json": [{"molecule_name": "scFv (TCT1067)-Auristatin-F-C5 DAR 3.3", "protein_target_name": null, "binding_metric": "Kd", "value": "32.8", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)-Auristatin-F-C5 DAR 5.65", "protein_target_name": null, "binding_metric": "Kd", "value": "40.3", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)-Auristatin-F-C5 DAR 1 1.9", "protein_target_name": null, "binding_metric": "Kd", "value": "810", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)", "protein_target_name": null, "binding_metric": "Kd", "value": "9.5", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe scFv (TCT1067)-DM1-dPEGi2 DAR 8 had an association rate of 1.32x10<sup>4</sup> M<sup>\"</sup> <sup>1</sup>s<sup>-1</sup> and a dissociation rate of 3.28 x10<sup>- 5</sup> s-, giving an overall binding Kd of 2.48nM.\nThe scFv (TCT1067)-DM1-dPEG<sub>12</sub> DAR 7 had an association rate of 1.95 x10<sup>4</sup> M<sup>-1</sup>s<sup>-1</sup> and a dissociation rate of 2.7 x10<sup>-5</sup> s<sup>-1</sup>, giving an overall binding Kd of 1.39nM.\nbut once bound, there was insignificant effect on the dissociation rate compared to the unmodified scFv (TCT1067) which had an association rate of 3.9x10<sup>6</sup> M<sup>-1</sup>s<sup>_1</sup> and a dissociation rate of 3.7x10<sup>-5</sup> s<sup>-1</sup>, with an overall binding Kd of 9.5 pM."}
{"final_json": [{"molecule_name": "scFv (TCT1067)-DM1-dPEGi2 DAR 8", "protein_target_name": null, "binding_metric": "Kd", "value": "2.48", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)-DM1-dPEG12 DAR 7", "protein_target_name": null, "binding_metric": "Kd", "value": "1.39", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "scFv (TCT1067)", "protein_target_name": null, "binding_metric": "Kd", "value": "9.5", "unit": "pM", "is_logarithmic": false}]}
